ArticleJournal of thoracic disease2022

A clinical risk model for assessing the survival of patients with stage IA-IIA non-small cell lung cancer after surgery.

Jia-Yi Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.